0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-inflammatory and Antipyretic Granules Market Research Report 2026
Published Date: 2026-03-17
|
Report Code: QYRE-Auto-32S17429
Home | Market Reports
Global Anti inflammatory and Antipyretic Granules Market Research Report 2024
BUY CHAPTERS

Global Anti-inflammatory and Antipyretic Granules Market Research Report 2026

Code: QYRE-Auto-32S17429
Report
2026-03-17
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-inflammatory and Antipyretic Granules Market

The global Anti-inflammatory and Antipyretic Granules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Anti-inflammatory and Antipyretic Granules competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Anti-inflammatory and Antipyretic Granules is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Anti-inflammatory and Antipyretic Granules is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Anti-inflammatory and Antipyretic Granules include Guangdong Baihe Pharmaceutical Co., Ltd., Shenyang Junyuan Pharmaceutical Co., Ltd., Guangxi Tiantianle Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Shaanxi Buchang Pharmaceutical Co., Ltd., Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd., Yunnan Baiyao Group Co., Ltd., Hubei Dongxin Pharmaceutical Co., Ltd., Dong'e Ejiao Co., Ltd., Jilin Xianfeng Technology Pharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Anti-inflammatory and Antipyretic Granules market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anti-inflammatory and Antipyretic Granules. The Anti-inflammatory and Antipyretic Granules market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Anti-inflammatory and Antipyretic Granules market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anti-inflammatory and Antipyretic Granules manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Anti-inflammatory and Antipyretic Granules Market Report

Report Metric Details
Report Name Anti-inflammatory and Antipyretic Granules Market
Segment by Type
  • Pack of 10
  • Pack of 16
by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Guangdong Baihe Pharmaceutical Co., Ltd., Shenyang Junyuan Pharmaceutical Co., Ltd., Guangxi Tiantianle Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Shaanxi Buchang Pharmaceutical Co., Ltd., Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd., Yunnan Baiyao Group Co., Ltd., Hubei Dongxin Pharmaceutical Co., Ltd., Dong'e Ejiao Co., Ltd., Jilin Xianfeng Technology Pharmaceutical Co., Ltd., Hubei Nordeson Pharmaceutical Co., Ltd., Sichuan Luye Pharmaceutical Co., Ltd., Yunnan Longfa Pharmaceutical Co., Ltd., Shaanxi Han Tang Pharmaceutical Co., Ltd., Jiangxi Jimin Kexin Pharmaceutical Co., Ltd., Liaoning Xingao Pharmaceutical Co., Ltd., Hebei Tiancheng Pharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Anti-inflammatory and Antipyretic Granules manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Anti-inflammatory and Antipyretic Granules sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-inflammatory and Antipyretic Granules Market report?

Ans: The main players in the Anti-inflammatory and Antipyretic Granules Market are Guangdong Baihe Pharmaceutical Co., Ltd., Shenyang Junyuan Pharmaceutical Co., Ltd., Guangxi Tiantianle Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Shaanxi Buchang Pharmaceutical Co., Ltd., Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd., Yunnan Baiyao Group Co., Ltd., Hubei Dongxin Pharmaceutical Co., Ltd., Dong'e Ejiao Co., Ltd., Jilin Xianfeng Technology Pharmaceutical Co., Ltd., Hubei Nordeson Pharmaceutical Co., Ltd., Sichuan Luye Pharmaceutical Co., Ltd., Yunnan Longfa Pharmaceutical Co., Ltd., Shaanxi Han Tang Pharmaceutical Co., Ltd., Jiangxi Jimin Kexin Pharmaceutical Co., Ltd., Liaoning Xingao Pharmaceutical Co., Ltd., Hebei Tiancheng Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Anti-inflammatory and Antipyretic Granules Market report?

Ans: The Applications covered in the Anti-inflammatory and Antipyretic Granules Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Anti-inflammatory and Antipyretic Granules Market report?

Ans: The Types covered in the Anti-inflammatory and Antipyretic Granules Market report are Pack of 10, Pack of 16

1 Anti-inflammatory and Antipyretic Granules Market Overview
1.1 Product Definition
1.2 Anti-inflammatory and Antipyretic Granules by Type
1.2.1 Global Anti-inflammatory and Antipyretic Granules Market Value by Type: 2025 vs 2032
1.2.2 Pack of 10
1.2.3 Pack of 16
1.3 Anti-inflammatory and Antipyretic Granules by Application
1.3.1 Global Anti-inflammatory and Antipyretic Granules Market Value by Application: 2025 vs 2032
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Anti-inflammatory and Antipyretic Granules Market Size Estimates and Forecasts
1.4.1 Global Anti-inflammatory and Antipyretic Granules Revenue 2021–2032
1.4.2 Global Anti-inflammatory and Antipyretic Granules Sales 2021–2032
1.4.3 Global Anti-inflammatory and Antipyretic Granules Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Anti-inflammatory and Antipyretic Granules Market Competition by Manufacturers
2.1 Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Manufacturers (2021–2026)
2.2 Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Anti-inflammatory and Antipyretic Granules Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Anti-inflammatory and Antipyretic Granules, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Anti-inflammatory and Antipyretic Granules, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Anti-inflammatory and Antipyretic Granules, Product Types and Applications
2.7 Global Key Manufacturers of Anti-inflammatory and Antipyretic Granules, Date of Entry into the Industry
2.8 Global Anti-inflammatory and Antipyretic Granules Market Competitive Situation and Trends
2.8.1 Global Anti-inflammatory and Antipyretic Granules Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Anti-inflammatory and Antipyretic Granules Players Market Share by Revenue
2.8.3 Global Anti-inflammatory and Antipyretic Granules Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-inflammatory and Antipyretic Granules Market Scenario by Region
3.1 Global Anti-inflammatory and Antipyretic Granules Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Anti-inflammatory and Antipyretic Granules Sales by Region: 2021–2032
3.2.1 Global Anti-inflammatory and Antipyretic Granules Sales by Region: 2021–2026
3.2.2 Global Anti-inflammatory and Antipyretic Granules Sales by Region: 2027–2032
3.3 Global Anti-inflammatory and Antipyretic Granules Revenue by Region: 2021–2032
3.3.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Region: 2021–2026
3.3.2 Global Anti-inflammatory and Antipyretic Granules Revenue by Region: 2027–2032
3.4 North America Anti-inflammatory and Antipyretic Granules Market Facts & Figures by Country
3.4.1 North America Anti-inflammatory and Antipyretic Granules Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Anti-inflammatory and Antipyretic Granules Sales by Country (2021–2032)
3.4.3 North America Anti-inflammatory and Antipyretic Granules Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-inflammatory and Antipyretic Granules Market Facts & Figures by Country
3.5.1 Europe Anti-inflammatory and Antipyretic Granules Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Anti-inflammatory and Antipyretic Granules Sales by Country (2021–2032)
3.5.3 Europe Anti-inflammatory and Antipyretic Granules Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-inflammatory and Antipyretic Granules Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-inflammatory and Antipyretic Granules Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Anti-inflammatory and Antipyretic Granules Sales by Region (2021–2032)
3.6.3 Asia Pacific Anti-inflammatory and Antipyretic Granules Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-inflammatory and Antipyretic Granules Market Facts & Figures by Country
3.7.1 Latin America Anti-inflammatory and Antipyretic Granules Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Anti-inflammatory and Antipyretic Granules Sales by Country (2021–2032)
3.7.3 Latin America Anti-inflammatory and Antipyretic Granules Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Country (2021–2032)
3.8.3 Middle East and Africa Anti-inflammatory and Antipyretic Granules Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021–2032)
4.1.1 Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021–2026)
4.1.2 Global Anti-inflammatory and Antipyretic Granules Sales by Type (2027–2032)
4.1.3 Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type (2021–2032)
4.2 Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2021–2032)
4.2.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2021–2026)
4.2.2 Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2027–2032)
4.2.3 Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type (2021–2032)
4.3 Global Anti-inflammatory and Antipyretic Granules Price by Type (2021–2032)
5 Segment by Application
5.1 Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021–2032)
5.1.1 Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021–2026)
5.1.2 Global Anti-inflammatory and Antipyretic Granules Sales by Application (2027–2032)
5.1.3 Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application (2021–2032)
5.2 Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2021–2032)
5.2.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2021–2026)
5.2.2 Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2027–2032)
5.2.3 Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application (2021–2032)
5.3 Global Anti-inflammatory and Antipyretic Granules Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Guangdong Baihe Pharmaceutical Co., Ltd.
6.1.1 Guangdong Baihe Pharmaceutical Co., Ltd. Company Information
6.1.2 Guangdong Baihe Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.1.5 Guangdong Baihe Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Shenyang Junyuan Pharmaceutical Co., Ltd.
6.2.1 Shenyang Junyuan Pharmaceutical Co., Ltd. Company Information
6.2.2 Shenyang Junyuan Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.2.5 Shenyang Junyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Guangxi Tiantianle Pharmaceutical Co., Ltd.
6.3.1 Guangxi Tiantianle Pharmaceutical Co., Ltd. Company Information
6.3.2 Guangxi Tiantianle Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.3.5 Guangxi Tiantianle Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Sichuan Kelun Pharmaceutical Co., Ltd.
6.4.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
6.4.2 Sichuan Kelun Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.4.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Shaanxi Buchang Pharmaceutical Co., Ltd.
6.5.1 Shaanxi Buchang Pharmaceutical Co., Ltd. Company Information
6.5.2 Shaanxi Buchang Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.5.5 Shaanxi Buchang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd.
6.6.1 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Company Information
6.6.2 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.6.5 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Yunnan Baiyao Group Co., Ltd.
6.7.1 Yunnan Baiyao Group Co., Ltd. Company Information
6.7.2 Yunnan Baiyao Group Co., Ltd. Description and Business Overview
6.7.3 Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.7.5 Yunnan Baiyao Group Co., Ltd. Recent Developments/Updates
6.8 Hubei Dongxin Pharmaceutical Co., Ltd.
6.8.1 Hubei Dongxin Pharmaceutical Co., Ltd. Company Information
6.8.2 Hubei Dongxin Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.8.5 Hubei Dongxin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Dong'e Ejiao Co., Ltd.
6.9.1 Dong'e Ejiao Co., Ltd. Company Information
6.9.2 Dong'e Ejiao Co., Ltd. Description and Business Overview
6.9.3 Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.9.5 Dong'e Ejiao Co., Ltd. Recent Developments/Updates
6.10 Jilin Xianfeng Technology Pharmaceutical Co., Ltd.
6.10.1 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Company Information
6.10.2 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.10.5 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Hubei Nordeson Pharmaceutical Co., Ltd.
6.11.1 Hubei Nordeson Pharmaceutical Co., Ltd. Company Information
6.11.2 Hubei Nordeson Pharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.11.5 Hubei Nordeson Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Sichuan Luye Pharmaceutical Co., Ltd.
6.12.1 Sichuan Luye Pharmaceutical Co., Ltd. Company Information
6.12.2 Sichuan Luye Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.12.5 Sichuan Luye Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Yunnan Longfa Pharmaceutical Co., Ltd.
6.13.1 Yunnan Longfa Pharmaceutical Co., Ltd. Company Information
6.13.2 Yunnan Longfa Pharmaceutical Co., Ltd. Description and Business Overview
6.13.3 Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.13.5 Yunnan Longfa Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Shaanxi Han Tang Pharmaceutical Co., Ltd.
6.14.1 Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information
6.14.2 Shaanxi Han Tang Pharmaceutical Co., Ltd. Description and Business Overview
6.14.3 Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.14.5 Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.
6.15.1 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Company Information
6.15.2 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Description and Business Overview
6.15.3 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.15.5 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.16 Liaoning Xingao Pharmaceutical Co., Ltd.
6.16.1 Liaoning Xingao Pharmaceutical Co., Ltd. Company Information
6.16.2 Liaoning Xingao Pharmaceutical Co., Ltd. Description and Business Overview
6.16.3 Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.16.5 Liaoning Xingao Pharmaceutical Co., Ltd. Recent Developments/Updates
6.17 Hebei Tiancheng Pharmaceutical Co., Ltd.
6.17.1 Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information
6.17.2 Hebei Tiancheng Pharmaceutical Co., Ltd. Description and Business Overview
6.17.3 Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
6.17.5 Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-inflammatory and Antipyretic Granules Industry Chain Analysis
7.2 Anti-inflammatory and Antipyretic Granules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-inflammatory and Antipyretic Granules Production Mode & Process Analysis
7.4 Anti-inflammatory and Antipyretic Granules Sales and Marketing
7.4.1 Anti-inflammatory and Antipyretic Granules Sales Channels
7.4.2 Anti-inflammatory and Antipyretic Granules Distributors
7.5 Anti-inflammatory and Antipyretic Granules Customer Analysis
8 Anti-inflammatory and Antipyretic Granules Market Dynamics
8.1 Anti-inflammatory and Antipyretic Granules Industry Trends
8.2 Anti-inflammatory and Antipyretic Granules Market Drivers
8.3 Anti-inflammatory and Antipyretic Granules Market Challenges
8.4 Anti-inflammatory and Antipyretic Granules Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Anti-inflammatory and Antipyretic Granules Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Anti-inflammatory and Antipyretic Granules Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Anti-inflammatory and Antipyretic Granules Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Anti-inflammatory and Antipyretic Granules Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Anti-inflammatory and Antipyretic Granules Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Anti-inflammatory and Antipyretic Granules Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Anti-inflammatory and Antipyretic Granules Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Anti-inflammatory and Antipyretic Granules, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Anti-inflammatory and Antipyretic Granules, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Anti-inflammatory and Antipyretic Granules, Product Types and Applications
 Table 12. Global Key Manufacturers of Anti-inflammatory and Antipyretic Granules, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anti-inflammatory and Antipyretic Granules Companies by Tier (Tier 1, Tier 2, Tier 3), based on Anti-inflammatory and Antipyretic Granules Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti-inflammatory and Antipyretic Granules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Anti-inflammatory and Antipyretic Granules Sales by Region (K Units), 2021–2026
 Table 18. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Region (2021–2026)
 Table 19. Global Anti-inflammatory and Antipyretic Granules Sales by Region (K Units), 2027–2032
 Table 20. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Region (2027–2032)
 Table 21. Global Anti-inflammatory and Antipyretic Granules Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Region (2021–2026)
 Table 23. Global Anti-inflammatory and Antipyretic Granules Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Region (2027–2032)
 Table 25. North America Anti-inflammatory and Antipyretic Granules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Anti-inflammatory and Antipyretic Granules Sales by Country (K Units), 2021–2026
 Table 27. North America Anti-inflammatory and Antipyretic Granules Sales by Country (K Units), 2027–2032
 Table 28. North America Anti-inflammatory and Antipyretic Granules Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Anti-inflammatory and Antipyretic Granules Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Anti-inflammatory and Antipyretic Granules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Anti-inflammatory and Antipyretic Granules Sales by Country (K Units), 2021–2026
 Table 32. Europe Anti-inflammatory and Antipyretic Granules Sales by Country (K Units), 2027–2032
 Table 33. Europe Anti-inflammatory and Antipyretic Granules Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Anti-inflammatory and Antipyretic Granules Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Anti-inflammatory and Antipyretic Granules Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Anti-inflammatory and Antipyretic Granules Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Anti-inflammatory and Antipyretic Granules Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Anti-inflammatory and Antipyretic Granules Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Anti-inflammatory and Antipyretic Granules Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Anti-inflammatory and Antipyretic Granules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Anti-inflammatory and Antipyretic Granules Sales by Country (K Units), 2021–2026
 Table 42. Latin America Anti-inflammatory and Antipyretic Granules Sales by Country (K Units), 2027–2032
 Table 43. Latin America Anti-inflammatory and Antipyretic Granules Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Anti-inflammatory and Antipyretic Granules Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Anti-inflammatory and Antipyretic Granules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Anti-inflammatory and Antipyretic Granules Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Anti-inflammatory and Antipyretic Granules Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Anti-inflammatory and Antipyretic Granules Sales (K Units) by Type (2021–2026)
 Table 51. Global Anti-inflammatory and Antipyretic Granules Sales (K Units) by Type (2027–2032)
 Table 52. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type (2021–2026)
 Table 53. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type (2027–2032)
 Table 54. Global Anti-inflammatory and Antipyretic Granules Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Anti-inflammatory and Antipyretic Granules Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type (2021–2026)
 Table 57. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type (2027–2032)
 Table 58. Global Anti-inflammatory and Antipyretic Granules Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Anti-inflammatory and Antipyretic Granules Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Anti-inflammatory and Antipyretic Granules Sales (K Units) by Application (2021–2026)
 Table 61. Global Anti-inflammatory and Antipyretic Granules Sales (K Units) by Application (2027–2032)
 Table 62. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application (2021–2026)
 Table 63. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application (2027–2032)
 Table 64. Global Anti-inflammatory and Antipyretic Granules Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Anti-inflammatory and Antipyretic Granules Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application (2021–2026)
 Table 67. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application (2027–2032)
 Table 68. Global Anti-inflammatory and Antipyretic Granules Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Anti-inflammatory and Antipyretic Granules Price (US$/Unit) by Application (2027–2032)
 Table 70. Guangdong Baihe Pharmaceutical Co., Ltd. Company Information
 Table 71. Guangdong Baihe Pharmaceutical Co., Ltd. Description and Business Overview
 Table 72. Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 74. Guangdong Baihe Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 75. Shenyang Junyuan Pharmaceutical Co., Ltd. Company Information
 Table 76. Shenyang Junyuan Pharmaceutical Co., Ltd. Description and Business Overview
 Table 77. Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 79. Shenyang Junyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Guangxi Tiantianle Pharmaceutical Co., Ltd. Company Information
 Table 81. Guangxi Tiantianle Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 84. Guangxi Tiantianle Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
 Table 86. Sichuan Kelun Pharmaceutical Co., Ltd. Description and Business Overview
 Table 87. Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 89. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 90. Shaanxi Buchang Pharmaceutical Co., Ltd. Company Information
 Table 91. Shaanxi Buchang Pharmaceutical Co., Ltd. Description and Business Overview
 Table 92. Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 94. Shaanxi Buchang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 95. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Company Information
 Table 96. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Description and Business Overview
 Table 97. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 99. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 100. Yunnan Baiyao Group Co., Ltd. Company Information
 Table 101. Yunnan Baiyao Group Co., Ltd. Description and Business Overview
 Table 102. Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 104. Yunnan Baiyao Group Co., Ltd. Recent Developments/Updates
 Table 105. Hubei Dongxin Pharmaceutical Co., Ltd. Company Information
 Table 106. Hubei Dongxin Pharmaceutical Co., Ltd. Description and Business Overview
 Table 107. Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 109. Hubei Dongxin Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 110. Dong'e Ejiao Co., Ltd. Company Information
 Table 111. Dong'e Ejiao Co., Ltd. Description and Business Overview
 Table 112. Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 114. Dong'e Ejiao Co., Ltd. Recent Developments/Updates
 Table 115. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Company Information
 Table 116. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Description and Business Overview
 Table 117. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 119. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 120. Hubei Nordeson Pharmaceutical Co., Ltd. Company Information
 Table 121. Hubei Nordeson Pharmaceutical Co., Ltd. Description and Business Overview
 Table 122. Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 124. Hubei Nordeson Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 125. Sichuan Luye Pharmaceutical Co., Ltd. Company Information
 Table 126. Sichuan Luye Pharmaceutical Co., Ltd. Description and Business Overview
 Table 127. Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 129. Sichuan Luye Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 130. Yunnan Longfa Pharmaceutical Co., Ltd. Company Information
 Table 131. Yunnan Longfa Pharmaceutical Co., Ltd. Description and Business Overview
 Table 132. Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 134. Yunnan Longfa Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 135. Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information
 Table 136. Shaanxi Han Tang Pharmaceutical Co., Ltd. Description and Business Overview
 Table 137. Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 139. Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 140. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Company Information
 Table 141. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Description and Business Overview
 Table 142. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 144. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 145. Liaoning Xingao Pharmaceutical Co., Ltd. Company Information
 Table 146. Liaoning Xingao Pharmaceutical Co., Ltd. Description and Business Overview
 Table 147. Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 149. Liaoning Xingao Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 150. Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information
 Table 151. Hebei Tiancheng Pharmaceutical Co., Ltd. Description and Business Overview
 Table 152. Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product
 Table 154. Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Anti-inflammatory and Antipyretic Granules Distributors List
 Table 158. Anti-inflammatory and Antipyretic Granules Customers List
 Table 159. Anti-inflammatory and Antipyretic Granules Market Trends
 Table 160. Anti-inflammatory and Antipyretic Granules Market Drivers
 Table 161. Anti-inflammatory and Antipyretic Granules Market Challenges
 Table 162. Anti-inflammatory and Antipyretic Granules Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti-inflammatory and Antipyretic Granules
 Figure 2. Global Anti-inflammatory and Antipyretic Granules Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Anti-inflammatory and Antipyretic Granules Market Share by Type: 2025 & 2032
 Figure 4. Pack of 10 Product Picture
 Figure 5. Pack of 16 Product Picture
 Figure 6. Global Anti-inflammatory and Antipyretic Granules Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Anti-inflammatory and Antipyretic Granules Market Share by Application: 2025 & 2032
 Figure 8. Online Sales
 Figure 9. Offline Sales
 Figure 10. Global Anti-inflammatory and Antipyretic Granules Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Anti-inflammatory and Antipyretic Granules Market Size (US$ Million), 2021–2032
 Figure 12. Global Anti-inflammatory and Antipyretic Granules Sales (K Units), 2021–2032
 Figure 13. Global Anti-inflammatory and Antipyretic Granules Average Price (US$/Unit), 2021–2032
 Figure 14. Anti-inflammatory and Antipyretic Granules Report Years Considered
 Figure 15. Anti-inflammatory and Antipyretic Granules Sales Share by Manufacturers in 2025
 Figure 16. Global Anti-inflammatory and Antipyretic Granules Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Anti-inflammatory and Antipyretic Granules Players: Market Share by Revenue in Anti-inflammatory and Antipyretic Granules in 2025
 Figure 18. Anti-inflammatory and Antipyretic Granules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Anti-inflammatory and Antipyretic Granules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021–2032)
 Figure 21. North America Anti-inflammatory and Antipyretic Granules Revenue Market Share by Country (2021–2032)
 Figure 22. United States Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021–2032)
 Figure 25. Europe Anti-inflammatory and Antipyretic Granules Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Anti-inflammatory and Antipyretic Granules Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Anti-inflammatory and Antipyretic Granules Revenue Market Share by Region (2021–2032)
 Figure 33. China Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Anti-inflammatory and Antipyretic Granules Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Colombia Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Anti-inflammatory and Antipyretic Granules Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Anti-inflammatory and Antipyretic Granules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Anti-inflammatory and Antipyretic Granules by Type (2021–2032)
 Figure 52. Global Revenue Market Share of Anti-inflammatory and Antipyretic Granules by Type (2021–2032)
 Figure 53. Global Anti-inflammatory and Antipyretic Granules Price (US$/Unit) by Type (2021–2032)
 Figure 54. Global Sales Market Share of Anti-inflammatory and Antipyretic Granules by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Anti-inflammatory and Antipyretic Granules by Application (2021–2032)
 Figure 56. Global Anti-inflammatory and Antipyretic Granules Price (US$/Unit) by Application (2021–2032)
 Figure 57. Anti-inflammatory and Antipyretic Granules Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension